Graylight imaging is ISO 13485 certified

FHS
August 28, 2024
11:16 am

In November 2023, we are proud to announce that we, Graylight Imaging, have successfully achieved ISO 13485 certified status, demonstrating our commitment to the highest quality standards in the design and manufacture of medical devices.

Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis – Biotech Investments

EQS-News: Imcyse SA / Key word(s): Study Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis 13.09.2023

September 14, 2023

Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to Supply Special Access Program | Psychedelic Finance

VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation

September 7, 2023

Healthcare’s Data Deluge is Intensifying Misdiagnosis

Eli Ben-Joseph, co-founder and CEO of Regard In 2019, my aunt was admitted to the hospital with heart failure. It was a harrowing experience for

June 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.